To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 January 2022 to Question 96909, on Cancer: Drugs, how many breast cancer drugs are being assessed through the Project Orbis licensing route.
Answered on
7 March 2022
The United Kingdom is aware of one Project Orbis product aimed at treating breast cancer. As with all medicines and treatments, the Medicines and Healthcare products Regulatory Agency (MHRA) will ensure a thorough and expedited assessment of any medicine’s safety and efficacy before any authorisation. The MHRA continues to work with other participants to review and approve applications for promising cancer treatments as quickly and efficiently as possible.
Answered by
Department of Health and Social Care